Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Cul4A-DDB1–mediated monoubiquitination of phosphoglycerate dehydrogenase promotes colorectal cancer metastasis via increased S-adenosylmethionine
Yajuan Zhang, Hua Yu, Jie Zhang, Hong Gao, Siyao Wang, Shuxian Li, Ping Wei, Ji Liang, Guanzhen Yu, Xiongjun Wang, Xinxiang Li, Dawei Li, Weiwei Yang
Yajuan Zhang, Hua Yu, Jie Zhang, Hong Gao, Siyao Wang, Shuxian Li, Ping Wei, Ji Liang, Guanzhen Yu, Xiongjun Wang, Xinxiang Li, Dawei Li, Weiwei Yang
View: Text | PDF
Research Article Metabolism Oncology

Cul4A-DDB1–mediated monoubiquitination of phosphoglycerate dehydrogenase promotes colorectal cancer metastasis via increased S-adenosylmethionine

  • Text
  • PDF
Abstract

Although serine metabolism plays a crucial role in the proliferation and survival of tumor cells, how it supports tumor cell migration remains poorly understood. Phosphoglycerate dehydrogenase (PHGDH) catalyzes the oxidation of 3-phosphoglycerate to 3-phosphonooxypyruvate, the first committed step in de novo serine biosynthesis. Here we show that PHGDH was monoubiquitinated by cullin 4A–based E3 ligase complex at lysine 146 in colorectal cancer (CRC) cells, which enhanced PHGDH activity by recruiting a chaperone protein, DnaJ homolog subfamily A member 1, to promote its tetrameric formation, thereby increasing the levels of serine, glycine, and S-adenosylmethionine (SAM). Increased levels of SAM upregulated the expression of cell adhesion genes (laminin subunit gamma 2 and cysteine rich angiogenic inducer 61) by initiating SET domain containing 1A–mediated trimethylation of histone H3K4, thereby promoting tumor cell migration and CRC metastasis. Intriguingly, SAM levels in tumors or blood samples correlated with the metastatic recurrence of patients with CRC. Our finding not only reveals a potentially new role and mechanism of SAM-promoted tumor metastasis but also demonstrates a regulatory mechanism of PHGDH activity by monoubiquitination.

Authors

Yajuan Zhang, Hua Yu, Jie Zhang, Hong Gao, Siyao Wang, Shuxian Li, Ping Wei, Ji Liang, Guanzhen Yu, Xiongjun Wang, Xinxiang Li, Dawei Li, Weiwei Yang

×

Figure 1

PHGDH activity is important for CRC metastasis.

Options: View larger image (or click on image) Download as PowerPoint
PHGDH activity is important for CRC metastasis.
(A–C) TCGA RNA-sequencin...
(A–C) TCGA RNA-sequencing data of patients with colon adenocarcinoma were analyzed. PHGDH mRNA levels were compared between tumors and paired normal tissues (A) or between different stages (B) (Wilcoxon’s signed-rank test). The boxes represent the median and the first and third quartiles, and the whiskers represent the minimum and maximum of all data points. Survival durations of 192 patients with low or high expression of PHGDH were compared (Kaplan-Meier method, C). (D–F) IHC analyses of PHGDH were performed in tumors and paired peritumoral tissues (D), primary tumors with or without metastatic recurrence (E), or paired primary tumors and metastatic tumors in the livers (F) from patients with CRC. Top, representative IHC staining images. Bottom, semiquantitative scoring (H score). D and F, paired t test, 2 tailed. E, Data represent mean ± SD (2-tailed t test). (G and H) HCT116 cells stably expressing shNT or PHGDH were infected with the lentivirus expressing rPHGDH WT or ED. Transwell migration assays were performed (G). Representative images (top) and statistical analyses (bottom) of the migrated cells were shown. Data represent mean ± SD of 3 biologically independent experiments. The cells were injected into spleens of randomized BALB/c nude mice. The metastatic nodules in the livers were counted and statistically analyzed (H). Data represent mean ± SD of 6 mice. One-way ANOVA with Tukey’s multiple-comparison test. Rel, relative. (I) Metastatic tumors were dissected from patients with CRC with hepatic metastasis and subcutaneously implanted into randomized BALB/c nude mice. Mice were treated with or without NCT-503. Metastatic nodules in the livers were counted and statistically analyzed. Data represent the mean ± SD of 6 mice (2-tailed t test). (J) Transwell migration assays were performed in HCT116 cells treated with or without 10 μM NCT-503. Data represent the mean ± SD of 3 biologically independent experiments (2-tailed t test). *P < 0.05, **P < 0.01. See also Supplemental Figure 1.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts